Current Protocols Editorial Board: Cell Biology
 |
Juan S. Bonifacino Juan S. Bonifacino holds a Ph. D. degree in biochemistry from the University of Buenos Aires, Argentina. In 1982, he moved to the U.S. National Institutes of Health (NIH) to pursue post-doctoral studies with Dr. Richard D. Klausner. He rose through the ranks and in 1997 became the Head of the Cell Biology and Metabolism Program of the National Institute of Child Health and Human Development, NIH. Throughout his career, Dr. Bonifacino has investigated the molecular mechanisms that determine protein localization and fate in the secretory and endocytic pathways of eukaryotic cells. In particular, he has conducted research on signals and adaptor proteins that mediate protein sorting to endosomes, lysosomes and related organelles. His group discovered new sorting signals and adaptor proteins (i.e., AP-3, AP-4, GGAs), and explained the mechanisms by which these function. In addition, Dr. Bonifacino applied the knowledge gained from these basic studies to the elucidation of the causes of human diseases such as the Hermansky-Pudlak syndrome type 2 and autosomal dominant polycystic liver disease. His work has been published in over 190 scholarly articles. Dr. Bonifacino serves or has served as associate editor of the journals Developmental Cell, Molecular Cell and Molecular Biology of the Cell, and editorial board member of The Journal of Cell Biology, The Journal of Biological Chemistry and Traffic. He has served as a member of the Council of the American Society for Cell Biology (ASCB) and chaired various scientific conferences. He has delivered the Alex Novikoff, Leo Satz and George Connell lectures, and is an Honorary Professor of Biological Chemistry at the University of Buenos Aires. |
 |
Mary Dasso Dr. Dasso obtained her B.A. in Chemistry from the University of Oregon. She was awarded a Marshall Scholarship to study at the University of Cambridge, where she obtained her Ph.D. in Biochemistry. She pursued postdoctoral studies at the University of California, San Diego. She has been a principal investigator at the National Institute for Child Health and Human Development since 1994. She has authored numerous publications regarding mitotic cell cycle regulation, mitotic spindle assembly and interphase nuclear function. |
 |
Joe B. Harford Dr. Joe Harford serves as Director of the Office of International Affairs (OIA) of the National Cancer Institute. In this capacity, he has responsibility for a number of bilateral and multilateral interactions between the NCI and foreign cancer research institutions. His office also tracks all funding going to foreign investigators through NCI grants and contracts as well as other forms of international collaboration. Dr. Harford serves as the Chair of the Strategic Advisory Group of the Ireland-Northern Ireland-NCI Cancer Consortium and as NCI liaison to the Middle East Cancer Consortium, the US-Japan Cooperative Cancer Research Program, and the International Network for Cancer Treatment and Research. Dr. Harford also represents the United States as a member of the Governing Council of the WHO's International Agency for Research on Cancer and as a member of the Board of Trustees of the Human Frontier Science Program, an international non-governmental, nonprofit association devoted to the promotion of basic research. Dr. Harford received his undergraduate degree in chemistry from Ohio University and his Ph.D. in biochemistry from the University of Maryland School of Medicine. He first came to the NIH in 1979 as a post-doctoral fellow and remained until 1993 at which time he was Deputy Director of the Cell Biology and Metabolism within NICHD. Dr. Harford's research efforts for this period involved receptor-mediated processes and the post-transcriptional regulation of genes involved in cellular iron metabolism. From 1993 to 1996, Dr. Harford directed the research efforts of RiboGene, Inc., a privately held biotechnology company in the San Francisco Bay Area. There, his research team focused upon unusual features of the process of protein synthesis in infectious pathogens and cancer. Under the direction of Dr. Harford, RiboGene, Inc. developed several high-throughput screens for new classes of therapeutic agents and obtained a number of Small Business Innovative Research grants from the NIH. Dr. Harford is a co-inventor on two issued U.S. patents. Dr. Harford currently chairs the NCI Technology Review Group with responsibility for actions related to the Institute's intellectual property. Dr. Harford has published over 100 scientific papers and served on the editorial boards for a number of scientific journals. He served as the Series Editor for Modern Cell Biology, a series of thematic volumes dealing with topics in molecular and cell biology. He edited the volume mRNA Metabolism and Post-transcriptional Gene Regulation for this series. Dr. Harford is one of the founding editors for Current Protocols in Cell Biology. |
 |
Jennifer Lippincott-Schwartz Jennifer Lippincott-Schwartz is Chief of the Section on Organelle Biology at the National Institute of Child Health and Human Development at the National Institutes of Health in Bethesda, MD. She attended Swarthmore College as an undergraduate and then obtained an MS in Biology from Stanford University before receiving a Ph.D in Biochemisty from the Johns Hopkins University in Baltimore, Maryland. After graduating in 1986, she pursued post-doctoral research at the National Institutes of Health in Bethesda, Maryland in the laboratory of Richard Klausner, characterizing the membrane trafficking pathways connecting the ER and Golgi apparatus. Dr. Lippincott-Schwartz is internationally recognized for her pioneering work in the development of green fluorescent protein (GFP) technology, including the introduction of photoactivatable GFP and the utilization of the super high-resolution technique of photoactivation localization microscopy (PALM). Using these and other innovative methods for analyzing the distribution and behavior of proteins within cells and embryos, Dr. Lippincott-Schwartz's group has made many landmark discoveries in cell compartmentalization and protein trafficking key to cell physiology. Dr. Lippincott-Schwartz was the recipient of the NIH Award of Merit, the Feulgin Prize by the Society of Histochemistry, and the Keith Porter Fellow Award. She was elected to serve on the Council of the American Society of Cell Biology and on the Council of the Biophysics Society. She is co-author of the textbook, Cell Biology, 2nd Edition, together with Drs. Thomas Pollard and William Earnshaw. She was elected to the National Academy of Sciences in May 2008. |
 |
Kenneth M. Yamada Research Interests: Mechanisms and regulation of cell adhesion, migration, and invasion; cell surface interactions in embryonic development, wound repair, and cancer; fibronectin and other extracellular matrix molecules; integrins; signal transduction; membrane-cytoskeletal interactions and regulation. Education: 1966: BA, Biological Sciences, Stanford University, Palo Alto, California 1971: PhD, Biological Sciences, Stanford University 1972: MD, Stanford University School of Medicine |
Most Popular Tools
Beyond the Bench
READ OUR EDITORS' BLOG for news, commentaries, and the latest developments in methods both in and out of the lab.
Discussion Boards
See what authors, experts, and peers are discussing.
